RMIT-led study highlights the urgent need for more drug testing facilities in Australia

NewAms­ter­dam Phar­ma’s lead car­dio pro­gram obice­trapib passed an­oth­er Phase 3 tri­al, demon­strat­ing its abil­i­ty to low­er “bad cho­les­terol” in com­bi­na­tion with a drug called eze­tim­ibe

Plus, news about 2sev­en­ty, No­vo Nordisk, CASI, Cal­ciMed­ica, X4, NeOnc, ANI, Al­imera, Holoclara, Nx­era, Fu­ture Pak, Van­da and Bay­er: Re­cur­sion Phar­ma­ceu­ti­cals is sell­ing $200M in